Delivra Health Brands Income Statement

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	9.37	13.37	12.38	9.88	8.24	8.11
Revenue Growth (YoY)	-1.44%	8.01%	25.26%	19.94%	1.63%	3.87%
Cost of Revenue	6.23	6.66	5.73	4.66	4.86	5.2
Gross Profit	5.12	6.78	6.4	4.82	2.6	1.92
Selling, General & Admin	5.59	6.07	5.77	4.7	6.15	8.31
Depreciation & Amortization Expenses	0.32	1.27	1.31	1.33	2.12	2.22
Research & Development	-	-	-	-	-	0.07
Other Operating Expenses	0.07	0.22	0.27	0.55	1.53	14.27
Total Operating Expenses	5.98	7.56	7.36	6.58	9.79	24.87
Operating Income	-0.96	-0.84	-0.71	-1.36	-6.41	-22.95
Total Non-Operating Income (Expense)	-0.05	-0.35	1.59	1.18	-0.6	-0.71
Pretax Income	-1.01	-1.19	0.88	-0.18	-7.01	-23.66
Net Income	-1.01	-1.19	0.88	-0.18	-7.01	-22.67
Earnings From Discontinued Operations	-	-	-	-	-	-5.87
Net Income to Common	-1.53	-1.19	0.88	-0.18	-7.01	-28.54
Shares Outstanding (Basic)	36	31	29	25	25	23
Shares Outstanding (Diluted)	36	31	29	25	25	23
Shares Change (YoY)	8.15%	9.44%	13.08%	-	11.80%	5.27%
EPS (Basic)	-0.02	-0.04	0.03	-0.01	-0.30	-1.30
EPS (Diluted)	-0.02	-0.04	0.03	-0.01	-0.30	-1.30
Free Cash Flow	-0.33	-0.75	0.76	-1.09	-4.45	-9.68
Free Cash Flow Per Share	-0.01	-0.02	0.03	-0.04	-0.18	-0.43
Gross Margin	54.64%	50.70%	51.70%	48.81%	31.61%	23.67%
Operating Margin	-10.23%	-6.29%	-5.74%	-13.79%	-77.80%	-283.06%
Profit Margin	-10.78%	-8.90%	7.08%	-1.86%	-85.07%	-279.66%
FCF Margin	-3.47%	-5.64%	6.11%	-11.01%	-54.02%	-119.40%
EBITDA	-0.64	0.43	0.6	-0.03	-4.29	-20.29
EBITDA Margin	-6.84%	3.19%	4.84%	-0.33%	-52.08%	-250.28%
EBIT	-0.96	-0.84	-0.71	-1.36	-6.41	-22.95
EBIT Margin	-10.23%	-6.29%	-5.74%	-13.79%	-77.80%	-283.06%